State Street
CRVO icon

State Street’s CervoMed CRVO Stock Holding History

State Street’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80.9K Hold
20,527
– – ﹤0.01% 4064
2025
Q4 		$162K Buy
20,527
+2,100
+11% +$16.9K ﹤0.01% 3947
2025
Q3 		$149K Sell
18,427
-500
-3% -$4.29K ﹤0.01% 3977
2025
Q2 		$119K Sell
18,927
-93,129
-83% -$794K ﹤0.01% 3946
2025
Q1 		$1.03M Sell
112,056
-4,200
-4% -$16K ﹤0.01% 3421
2024
Q4 		$272K Buy
116,256
+11,800
+11% +$115K ﹤0.01% 3778
2024
Q3 		$1.53M Buy
104,456
+22,903
+28% +$355K ﹤0.01% 3404
2024
Q2 		$1.4M Buy
+81,553
New +$1.78M ﹤0.01% 3420
2022
Q2 		– Sell
-6,128
Closed -$115K – 4947
2022
Q1 		$115K Hold
6,128
– – ﹤0.01% 4601
2021
Q4 		$140K Hold
6,128
– – ﹤0.01% 4486
2021
Q3 		$234K Hold
6,128
– – ﹤0.01% 4296
2021
Q2 		$336K Buy
+6,128
New +$339K ﹤0.01% 4010

Other funds holding CRVO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street's CRVO Position: Q1 2026 in Review

State Street held its CervoMed (CRVO) position steady in Q1 2026 at 20,527 shares worth $80.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4064.

State Street first reported a position in CRVO in Q2 2021 and has held it in 12 quarters since. The position peaked at $1.53M in Q3 2024. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

  • State Street held 20,527 shares of CervoMed worth $80.9K as of Q1 2026.
  • State Street left its CervoMed share count unchanged in Q1 2026.
  • CervoMed made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4064 holding.
  • State Street first reported a position in CervoMed in Q2 2021 and has held it in 12 quarters since.
  • State Street's CervoMed position peaked at $1.53M in Q3 2024.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.